Pancreatic Cancer Research

ResearcherMie UniversityActive in the last 2 years

Hiroyuki Inoue

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6522-0886; OpenAlex author ID A5103163892. Sources: OpenAlex.

Their work

Papers
11
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 11

  1. Plexin Domain Containing 2, a Protein Specifically Expressed and Elevated in Human Pancreatic Cancer Tissue and Serum, Influences Cell Proliferation by Correla… Co-author DOI 10.1002/cam4.71459↗
  2. Extracellular vesicles from pancreatic ductal adenocarcinoma endoscopic ultrasound-fine needle aspiration samples contain a protein barcode. Co-author DOI 10.1002/jhbp.1048↗
  3. Trial protocol: a randomised controlled trial to verify the non-inferiority of a partially covered self-expandable metal stent to an uncovered self-expandable … Co-author DOI 10.1136/bmjopen-2020-045698↗
  4. Improving the Prognosis of Pancreatic Cancer Through Early Detection: Protocol for a Prospective Observational Study. Co-author DOI 10.2196/26898↗
  5. miR-3940-5p/miR-8069 ratio in urine exosomes is a novel diagnostic biomarker for pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ol.2020.11357↗
  6. Comparison of endoscopic ultrasound-guided fine-needle aspiration and biopsy with 22-gauge and 25-gauge needles for the "precision medicine" of pancreatic canc… Co-author DOI 10.1097/md.0000000000011096↗
  7. Pancreatic Adenocarcinoma Producing Parathyroid Hormone-Related Protein. Co-author DOI 10.1155/2017/5656130↗
  8. Human Equilibrative Nucleoside Transporter 1 Expression in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration Biopsy Samples Is a Strong Predictor of Cli… Co-author DOI 10.1097/mpa.0000000000000597↗
  9. Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of th… Co-author DOI 10.1097/mpa.0000000000000059↗
  10. Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoper… Co-author DOI 10.1007/s00534-011-0440-3↗
  11. Impact of histological response after neoadjuvant chemoradiotherapy on recurrence-free survival in UICC-T3 pancreatic adenocarcinoma but not in UICC-T4. Co-author DOI 10.1097/mpa.0b013e3182236442↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yoshiyuki Takei · 6 shared papers, 2016–2025 · strength 0.63
  2. Reiko Yamada · 6 shared papers, 2016–2025 · strength 0.62
  3. Junya Tsuboi · 4 shared papers, 2016–2025 · strength 0.48
  4. Naohiko Yoshizawa · 4 shared papers, 2017–2025 · strength 0.43
  5. Yasuhiro Murata · 5 shared papers, 2012–2021 · strength 0.24
  6. Shuji Isaji · 5 shared papers, 2012–2021 · strength 0.24
  7. Shugo Mizuno · 5 shared papers, 2012–2021 · strength 0.24
  8. Masashi Kishiwada · 5 shared papers, 2012–2021 · strength 0.24
  9. Masatoshi Watanabe · 1 shared paper, 2025 · strength 0.19
  10. Hayato Nakagawa · 1 shared paper, 2025 · strength 0.19
  11. Eri Usugi · 1 shared paper, 2022 · strength 0.15
  12. Taizo Shiraishi · 4 shared papers, 2012–2016 · strength 0.14
  13. Makoto Yoshida · 1 shared paper, 2021 · strength 0.11
  14. Masaki Kuwatani · 1 shared paper, 2021 · strength 0.11
  15. Masahiro Itonaga · 1 shared paper, 2021 · strength 0.11
  16. Shinichi Hashimoto · 1 shared paper, 2021 · strength 0.11
  17. Hirotoshi Ishiwatari · 1 shared paper, 2021 · strength 0.11
  18. Kazumichi Kawakubo · 1 shared paper, 2021 · strength 0.11
  19. Naoya Sakamoto · 1 shared paper, 2021 · strength 0.11
  20. Shin Kato · 1 shared paper, 2021 · strength 0.11
  21. Takuji Iwashita · 1 shared paper, 2021 · strength 0.11
  22. Akio Katanuma · 1 shared paper, 2021 · strength 0.11
  23. Yusuke Mizukami · 1 shared paper, 2021 · strength 0.11
  24. Aoi Hayasaki · 1 shared paper, 2021 · strength 0.10
  25. Yoshihiro Kondo · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.